- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Swedish Orphan Biovitrum AB (SOBIV)
321.00
+2.40(+0.75%)
Closed
Fair Value
An estimate of a stock's true price based on valuation of 49 models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
316.80
324.00
52 wk Range
206.20
324.00
SOBIV Scorecard
Full Analysis
Trading at a high earnings multiple
Trading near 52-week High
Swedish Orphan Biovitrum AB stock price live, this page displays ST SOBIV stock exchange data. View the SOBIV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Swedish Orphan Biovitrum AB real time stock price chart below.
What Is the Swedish Orphan Biovitrum AB Stock Price Today?
The Swedish Orphan Biovitrum AB stock price today is 321.00.
What Is the Stock Symbol for Swedish Orphan Biovitrum AB?
The stock ticker symbol for Swedish Orphan Biovitrum AB is SOBIV.
Is SOBIV the Same as $SOBIV?
$SOBIV is a common way to refer to the Swedish Orphan Biovitrum AB ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Swedish Orphan Biovitrum AB Trade On?
Swedish Orphan Biovitrum AB is listed and trades on the Stockholm stock exchange.
Is Swedish Orphan Biovitrum AB a Good Stock to Buy?
Determining whether Swedish Orphan Biovitrum AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Swedish Orphan Biovitrum AB share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SOBIV quote. (ISIN: SE0000872095)
What Is the Swedish Orphan Biovitrum AB Stock Price Today?
The Swedish Orphan Biovitrum AB stock price today is 321.00.
What Is the Stock Symbol for Swedish Orphan Biovitrum AB?
The stock ticker symbol for Swedish Orphan Biovitrum AB is SOBIV.
Is SOBIV the Same as $SOBIV?
$SOBIV is a common way to refer to the Swedish Orphan Biovitrum AB ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Swedish Orphan Biovitrum AB Trade On?
Swedish Orphan Biovitrum AB is listed and trades on the Stockholm stock exchange.
Is Swedish Orphan Biovitrum AB a Good Stock to Buy?
Determining whether Swedish Orphan Biovitrum AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Swedish Orphan Biovitrum AB share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SOBIV quote. (ISIN: SE0000872095)
Fair Value
An estimate of a stock's true price based on valuation of 49 models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
316.80324.00
52 wk Range
206.20324.00
UnlockSOBIV Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation of 49 models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Price Target
328.91
Upside
+2.46%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Biotechnology industry
Swedish Orphan Biovitrum AB Company Profile
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia. It offers Alprolix for haemophilia B; Aspaveli®/Empaveli for the treatment of adult patients with paroxysmal nocturnal haemoglobinuria; Doptelet treatment of thrombocytopenia; Elocta for haemophilia A; Gamifant for hemophagocytic lymphohistiocytosis(HLH); VONJO for the treatment of adults with intermediate or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis; Zynlonta, an aggressive malignant disease; Kineret for cryopyrin associated periodic syndrome, rheumatoid arthritis, and still's disease; Orfadin to treat hereditary tyrosinaemia type-1; and Synagis for serious lower respiratory tract infection. The company also provides other products, such as Akynzeo, Tegsedi, Jyseleca, Kepivance, Aloxi, and Waylivra. In addition, it develops drug substance for ReFacto AF/Xyntha for Pfizer; BIVV001 for haemophilia A; and Nirsevimab for respiratory syncytial virus. The company has a strategic collaboration with Sanofi, Apellis Pharmaceuticals Inc., ADC Therapeutics SA, and Cartesian Therapeutics, Inc. Swedish Orphan Biovitrum AB (publ) was incorporated in 1939 and is headquartered in Solna, Sweden.
Compare SOBIV to Peers and Sector
Metrics to compare | SOBIV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSOBIVPeersSector | |
|---|---|---|---|---|
P/E Ratio | 51.6x | −1.8x | −0.6x | |
PEG Ratio | −1.33 | −0.03 | 0.00 | |
Price / Book | 3.0x | 1.7x | 2.6x | |
Price / LTM Sales | 4.7x | 8.1x | 3.1x | |
Upside (Analyst Target) | 2.8% | 115.3% | 57.6% | |
Fair Value Upside | Unlock | 25.4% | 7.3% | Unlock |
People Also Watch
FAQ
What Is the Swedish Orphan Biovitrum (SOBIV) Stock Price Today?
The Swedish Orphan Biovitrum stock price today is 321.00
What Stock Exchange Does Swedish Orphan Biovitrum Trade On?
Swedish Orphan Biovitrum is listed and trades on the Stockholm stock exchange.
What Is the Stock Symbol for Swedish Orphan Biovitrum?
The stock symbol for Swedish Orphan Biovitrum is "SOBIV."
What Is the Swedish Orphan Biovitrum Market Cap?
As of today, Swedish Orphan Biovitrum market cap is 109.95B.
What is Swedish Orphan Biovitrum Earnings Per Share?
The Swedish Orphan Biovitrum EPS is 6.35.
What Is the Next Swedish Orphan Biovitrum Earnings Date?
Swedish Orphan Biovitrum will release its next earnings report on Oct 24, 2024.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.